Implementation of a CKD checklist for primary care providers.
暂无分享,去创建一个
Sushrut S Waikar | Karandeep Singh | D. Leaf | L. Schneider | S. Waikar | M. Mendu | Thomas H. Lee | Karandeep Singh | A. Aizer | David E Leaf | Thomas H Lee | Louise I Schneider | Ayal A Aizer | Mallika L Mendu
[1] D. Elbourne,et al. Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects☆ , 2014, Journal of clinical epidemiology.
[2] K. Inaba,et al. Measurable outcomes of quality improvement using a daily quality rounds checklist: Two-year prospective analysis of sustainability in a surgical intensive care unit , 2013, The journal of trauma and acute care surgery.
[3] A. Levin,et al. Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.
[4] Roland E Schmieder,et al. Clinical situations associated with difficult-to-control hypertension , 2013, Journal of hypertension.
[5] C. Bridges,et al. Recommended adult immunization schedule-United States, 2013. , 2013, Journal of midwifery & women's health.
[6] Stephen D. Persell,et al. Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis , 2012, BMC Health Services Research.
[7] J. Timsit,et al. A multifaceted program for improving quality of care in intensive care units: IATROREF study* , 2012, Critical care medicine.
[8] J. Weissfeld,et al. Comorbidity as a Mediator of Survival Disparity Between Younger and Older Women Diagnosed With Metastatic Breast Cancer , 2012, Hypertension.
[9] Keith C. Norris,et al. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). , 2012, Archives of internal medicine.
[10] M. Landray,et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.
[11] Abigail Shefer,et al. Recommended Adult Immunization Schedule: United States, 2011* , 2011, Annals of Internal Medicine.
[12] Raquel C. Greer,et al. Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions , 2011, BMC nephrology.
[13] David W. Bates,et al. Primary Care Management of Chronic Kidney Disease , 2011, Journal of General Internal Medicine.
[14] S. de Lusignan,et al. Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.
[15] D. Jonas,et al. Systematic Review: Enhancing the Use and Quality of Colorectal Cancer Screening , 2010, Annals of Internal Medicine.
[16] V. Jeevanantham,et al. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. , 2010, Clinical nephrology.
[17] Ian J. Stewart,et al. Chronic kidney disease management in an academic internal medicine clinic , 2010, Clinical and Experimental Nephrology.
[18] W. Berry,et al. A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population , 2009, The New England journal of medicine.
[19] Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] S. Derose,et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] Spyridon S Marinopoulos,et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. , 2008, Journal of clinical epidemiology.
[22] Chester H. Fox,et al. Improving Chronic Kidney Disease Care in Primary Care Practices: An Upstate New York Practice-based Research Network (UNYNET) Study , 2008, The Journal of the American Board of Family Medicine.
[23] K. Kalantar-Zadeh,et al. Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[24] Daniel C. Brennan,et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review , 2008, Clinical and Experimental Nephrology.
[25] A. Gawande,et al. The checklist: if something so simple can transform intensive care, what else can it do? , 2007, New Yorker.
[26] H. Manley. Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management , 2007, Journal of managed care pharmacy : JMCP.
[27] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[28] Dose conversions: opportunity for error. , 2007, The American journal of medicine.
[29] J. Goddard,et al. What are the best treatments for early chronic kidney disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] Jerome D. Cohen,et al. Overview of physiology, vascular biology, and mechanisms of hypertension. , 2007, Journal of managed care pharmacy : JMCP.
[31] J. Ingelfinger. Through the looking glass: anemia guidelines, vested interests, and distortions. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[32] M. Tonelli,et al. NSAID use and progression of chronic kidney disease. , 2007, The American journal of medicine.
[33] N. Powe,et al. Identification and referral of patients with progressive CKD: a national study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] H. Clark,et al. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] G. Bakris,et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. , 2005, Archives of internal medicine.
[36] Evelyn P Whitlock,et al. Screening for Abdominal Aortic Aneurysm: A Best-Evidence Systematic Review for the U.S. Preventive Services Task Force , 2005, Annals of Internal Medicine.
[37] Zhongxin Zhang,et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.
[38] A. Kausz,et al. The Value of Vaccination in Chronic Kidney Disease , 2004, Seminars in dialysis.
[39] Neil R. Powe,et al. Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease , 2003, Epidemiology.
[40] G. Eknoyan. Meeting the challenges of the new K/DOQI guidelines. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[41] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[42] S. Woolf,et al. Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.
[43] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] Kdoqi Disclaimer. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] C. Schmid,et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.
[47] C. Schmid,et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. , 2001, Annals of internal medicine.
[48] B. Pereira,et al. Optimization of pre-ESRD care: the key to improved dialysis outcomes. , 2000, Kidney international.
[49] L. Agodoa,et al. United States Renal Data System (USRDS). , 2000, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[50] M. Cabana,et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.
[51] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[52] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[53] T. Greene,et al. Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.
[54] T. Louis,et al. Long-term effects of antihypertensive agents on proteinuria and renal function. , 1995, Archives of internal medicine.
[55] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[56] S. Klahr. The modification of diet in renal disease study. , 1989, The New England journal of medicine.